About this trial
The TRI-MOM program aims to implement and evaluate a simplified (based on inexpensive rapid diagnostic tests), integrated (in governmental health facilities) and coordinated (between health care workers) strategy for the triple elimination of HIV, syphilis and HBV mother-to-child transmission (MTCT) in nine maternal and child health services, 5 in Burkina Faso and 5 in The Gambia.
The TRI-MOM program has two components:
1. an "intervention" component consisting of a pilot study to reinforce the antenatal screening and prevention of MTCT (PMTCT) capacities for the 3 targeted infections through the implementation of a simplified, integrated and coordinated strategy of triple elimination of MTCT. 2. an "evaluation" component which will assess the impact of the TRI-MOM strategy on PMTCT services, reduction of HBV MTCT and women empowerment.
Eligibility criteria
Qualifiers
Women attending a postnatal visit in one of the selected maternities (no maternal age limit)
Disqualifiers
Refusal to participate in the study
Unable to provide consent
Trial design
Treatments tested in this trial
- TRI-MOM intervention
Treatment groups
Sponsors and collaborators
Institut de Recherche pour le Developpement
Lead sponsor
Centre Muraz
Collaborator
Medical Research Council
Collaborator
Institut Pasteur
Collaborator
REVS PLUS Burkina Faso
Collaborator
Young Gambian Mums Fund
Collaborator
National AIDS Control Program Gambia
Collaborator